on NEOVACS (EPA:ALNEV)
Neovacs organizes a meeting on Lipid Nanoparticles and RNA
On March 28, 2025, the biopharmaceutical company Neovacs announced its co-organization of the first French meeting dedicated to Lipid Nanoparticles for RNA delivery. The event will be held at the Faculty of Pharmacy of Paris on April 3, 2025, in collaboration with the French Society of Nanomedicine (SFNano).
This meeting, initiated by Dr. Mignet of Paris Cité University, will bring together academic and industry experts, including Dr. Lemdani and Dr. Serra of Néovacs. It aims to discuss advances in the development of mRNA-based therapies and vaccines, a booming sector.
Neovacs has also launched a research program on severe asthma, recognized for its valuation between 56 and 98 million euros, according to In Extenso Innovation Croissance.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NEOVACS news